Brunner's Gland Stem Cell Isolation via Osmotic Shock and Magnetic Sorting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for isolating Brunner's Gland stem/progenitor cells (BGSCs) from adult duodena, which are crucial for various clinical and therapeutic applications due to their unique properties and accessibility via endoscopy, but existing techniques have not successfully achieved their isolation.
Innovation Solution
A method involving osmotic shock, mechanical or chemical disruption, and subsequent digestion to isolate BGSCs expressing specific markers such as Tra-1-60, Tra-1-81, OCT4, SOX2, NANOG, EpCAM, SOX9, Lgr5, NIS, CD44, and SOX17, allowing for their proliferation and self-renewal in culture conditions, including serum-free media like Kubota's Medium.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional isolation methods are used, then the procedure is simple, but Brunner's Gland stem/progenitor cells cannot be successfully isolated
Solution Approach 1:
The isolation procedure is divided into distinct sequential steps: osmotic shock treatment to detach mucosal cells, mechanical disruption to release glandular structures, enzymatic digestion to separate individual cells, and magnetic-activated cell sorting to isolate BGSCs. Each step targets a specific barrier to successful isolation, transforming an impossible single-step process into a reliable multi-step protocol.
Solution Approach 2:
Osmotic shock treatment is applied before mechanical disruption to pre-soften and detach the mucosal layer, making subsequent steps more effective. This preliminary action reduces the mechanical force needed and improves cell recovery, addressing the complexity-reliability tradeoff by preparing the tissue in advance.
2Adaptability or versatility
If stem cells are isolated for therapeutic use, then clinical applications are enabled, but contamination risks increase
Solution Approach 1:
Magnetic beads coated with stem cell-specific antibodies serve as intermediaries to selectively bind and isolate BGSCs from the complex tissue digest. This intermediary approach enables specific cell capture while excluding contaminants, and the magnetic separation provides a closed-system method that minimizes contamination risk during the isolation process.
Solution Approach 2:
Traditional mechanical filtration and centrifugation methods are replaced with magnetic-activated cell sorting, which uses magnetic field forces instead of mechanical forces to separate cells. This substitution reduces mechanical stress on isolated cells and provides more controlled, reproducible separation with lower contamination risk.
3Productivity
If BGSCs are maintained in culture, then proliferation is achieved, but differentiation may occur
Solution Approach 1:
The culture medium composition is precisely controlled with specific growth factors (EGF, bFGF, insulin), hormones (hydrocortisone), and supplements (B27, N2) to create optimal conditions for stem cell maintenance. The medium is formulated without serum to avoid undefined factors that could trigger differentiation, while providing all necessary nutrients for sustained proliferation and stemness preservation.
Solution Approach 2:
The culture system is designed for continuous passage and expansion of BGSCs through regular subculturing. By maintaining cells in an undifferentiated state through optimized culture conditions and及时 passaging, the system enables continuous production of stem cells for therapeutic applications without loss of stemness or accumulation of differentiated cells.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the isolation and prolonged proliferation of BGSCs, facilitating their use in autologous or allogeneic cell therapies, drug testing, and disease treatment by maintaining their stemness and multipotency, with the potential for differentiation into liver and pancreatic cell types.
Implementation Method 1
removal of the mucosa by treatment with a hypotonic solution under conditions of osmotic shock
Implementation Method 2
digestion of the submucosa with collagenase and dispase
Implementation Method 3
magnetic-activated cell sorting to isolate the stem cells
Data Source
AI summary
Disclosed herein is Brunner's Gland Stem/Progenitor Cells (BGSCs) having phenotypic traits of endodermal stem cells and positive for pluripotency markers, and methods of isolating them from the human duodenum. Moreover, the present disclosure provides that BGSCs are easily isolated from duodenum from human donors, can be expanded in culture or induced to differentiate towards hepatic and pancreatic lineages and could represent a cell source for clinical programs of regenerative medicine.